Home / Research library / MOTS-c
MOTS-c: molecular data, studies & sources
MOTS-c is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C101H152N28O22S2
- Molecular weight (MW)
- 2174.6 g/mol
- PubChem compound ID
- 146675088
- Record title
- Mots-c
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 146675088 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid
- InChIKey
- WYTHCOXVWRKRAH-LOKRTKBUSA-N
- SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)N
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Circulating levels of MOTS-c in patients with breast cancer treated with metformin.
Cuyàs E, Verdura S, Martin-Castillo B et al. · Aging · 2022
PMID 36490309 · DOI: 10.18632/aging.204423
- Human study · PubMed trial index
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors.
Dieli-Conwright CM, Sami N, Norris MK et al. · Scientific reports · 2021
PMID 34413391 · DOI: 10.1038/s41598-021-96419-z
- Human study · PubMed trial index
Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization.
Elhusseiny R, Ihsan M, Labidi M et al. · Medicine and science in sports and exercise · 2025
PMID 40674654 · DOI: 10.1249/MSS.0000000000003825
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.
Zheng Y, Wei Z, Wang T et al. · Frontiers in endocrinology · 2023
PMID 36761202 · DOI: 10.3389/fendo.2023.1120533
- Research publication · design requires review
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
Lee C, Zeng J, Drew BG et al. · Cell metabolism · 2015
PMID 25738459 · DOI: 10.1016/j.cmet.2015.02.009
- Research publication · design requires review
Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination.
Yin Y, Li Y, Ma B et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
PMID 39321430 · DOI: 10.1002/advs.202405620
MOTS-c supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all MOTS-c sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Blank PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $55.00Checked Sep 21, 2026Supplier listing |
| American PeptidesUSD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · $100.00Checked Sep 21, 2026Supplier listing |
| Modified AminosUSD | 10mg Vial · 20mg Vial2 recorded offers | 10mg Vial · $34.95Checked Sep 16, 2026Supplier listing |
| Amino ClubUSD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · $39.99Checked Sep 16, 2026Supplier listing |
| Nova Peptide SupplyUSD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · $49.99Checked Sep 16, 2026Supplier listing |
| Amino USAUSD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · $45.00Checked Sep 16, 2026Supplier listing |
| Cenexa LabsUSD | 40mg Vial · 10mg Vial2 recorded offers | 40mg Vial · $189.99Checked Sep 16, 2026Supplier listing |
| US Peptide LabsUSD | 20mg Vial1 recorded offers | 20mg Vial · $95.00Checked Sep 16, 2026Supplier listing |
| Direct PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $49.00Checked Sep 16, 2026Supplier listing |
| Particle PeptidesEUR | 10mg Vial1 recorded offers | 10mg Vial · €47.99Checked Sep 16, 2026Supplier listing |
| PeptiLabCAD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · CA$95.00Checked Sep 17, 2026Supplier listing |
| Nuvion PeptidesCAD | 40mg Vial1 recorded offers | 40mg Vial · CA$129.99Checked Sep 21, 2026Supplier listing |
| AminoVaultUSD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · $59.49Checked Sep 19, 2026Supplier listing |
| PhaseOneAUD | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · A$63.99Checked Sep 21, 2026Supplier listing |
| BioStacksCAD | 10mg Vial · 20mg Vial2 recorded offers | 10mg Vial · CA$90.00Checked Sep 21, 2026Supplier listing |
| PepspanEUR | 10mg Vial1 recorded offers | 10mg Vial · €74.90Checked Sep 21, 2026Supplier listing |
| AllMyPeptidesGBP | 10mg Vial · 40mg Vial2 recorded offers | 10mg Vial · £24.99Checked Sep 17, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 146675088 — chemical identity and structure.
- Wikipedia: MOTS-c — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
5-Amino-1MQ
C10H11N2+
159.21 g/mol · PubChem CID 950107
0 selected publications · 0 human study records
FOXO4-DRI
C228H388N86O64
5358 g/mol · PubChem CID 167312269
4 selected publications · 0 human study records
GHK-Cu
C14H23CuN6O4+
402.92 g/mol · PubChem CID 71587328
1 selected publications · 0 human study records
Glutathione
C10H17N3O6S
307.33 g/mol · PubChem CID 124886
7 selected publications · 4 human study records
Humanin
C119H204N34O32S2
2687.2 g/mol · PubChem CID 16131438
1 selected publications · 1 human study records
NAD+
C21H27N7O14P2
663.4 g/mol · PubChem CID 5892
1 selected publications · 1 human study records